2016 Hematological Malignancies

SWOG: CHOP vs 3 intensive regimens in advanced NHL

Patients 3-year estimate (%) at risk 225 54 223 52 233 50 218 50 p = 0.90

CHOP m-BACOD ProMACE-CytaBOM MACOP-B

100

80

60

40

20

% of treatment group 0

0

2 4 6

Years after randomization

Fischer et al. NEJM 1993; 328: 1002–6